MedCity News
MARCH 17, 2024
The U.S. Department of Justice has reportedly recently launched an antitrust investigation of UnitedHealth Group, which begs the question of whether the healthcare giant should be broken up. Experts have varying opinions.
Fierce Pharma
MARCH 20, 2024
Four months ago, when BioNTech slashed its 2023 revenue projection from 5 billi | When BioNTech reported its fourth-quarter earnings Wednesday, it was another harsh reminder of the plummeting demand for COVID-19 vaccines. Sales came to 1.5 billion euros ($1.6 billion) for the fourth quarter and 3.8 billion euros ($4.1 billion) for 2023, coming up short of expectations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Integrity Solutions
MARCH 19, 2024
As a sales leader have you looked at your forecast and asked questions like these: “Do we have enough opportunities in our forecast to confidently make our goal this quarter/year?” “We may have enough opportunities, but are they large enough in terms of projected revenue? What is our go-get?” “Are we progressing these opportunities through our pipeline process towards close?
PharmaVoice
MARCH 21, 2024
New tools that allow researchers to separate single cells can help map the complex web of proteins that lead to disease, providing new targets for biopharma.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
MARCH 20, 2024
The regulatory environment and workforce shortages are plaguing the pharmacy industry, one Walgreens exec shared at the Abarca Forward conference on Tuesday.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Infuse Medical
MARCH 22, 2024
Healthcare training is a crucial aspect of maintaining high standards in patient care and ensuring the competence of medical professionals. However, traditional methods of training often come with significant costs and limitations. In recent years, the integration of Virtual Reality (VR) technology has emerged as a promising solution to mitigate these challenges.
PharmaVoice
MARCH 19, 2024
Curevo Vaccine is readying a phase 3 trial for a candidate it believes could have an edge over GSK’s blockbuster Shingrix.
MedCity News
MARCH 21, 2024
Through a new strategic alliance, Prime Therapeutics will be the only PBM — aside from Capital Rx — to use Capital Rx’s JUDI platform.
Fierce Pharma
MARCH 19, 2024
This year marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the company's red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nat | 2024 marks Novo Nordisk’s 30th anniversary in China, and it could also be the year the Danish drugmaker’s red-hot weight loss injection Wegovy (semaglutide) wins approval in the populous East Asian nation.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Infuse Medical
MARCH 22, 2024
In today’s rapidly evolving healthcare landscape, the integration of cutting-edge technologies like Virtual Reality (VR) is transforming the way medical professionals are trained and patients are cared for. As healthcare organizations seek innovative solutions to enhance training effectiveness, improve patient outcomes, and streamline operations, the demand for high-quality VR training providers has surged.
PharmaVoice
MARCH 18, 2024
Aily Labs’ tech makes predictive business decisions for life science companies and comes from a need its founder witnessed in Big Pharma.
MedCity News
MARCH 21, 2024
Many people don’t take well to the term “healthcare consumer,” or have expressed that they prefer to be referred to as a patient rather than a consumer. But in the U.S., it’s a plain fact that people have choices when it comes to their healthcare. In this piece, three health system executives give their take on why “patient” and “consumer” are often one in the same — and why hospitals need to be mindful of this.
Fierce Pharma
MARCH 20, 2024
After scoring an FDA nod Monday for the first gene therapy to treat the rare genetic disease metachromatic leukodystrophy (MLD) in the U.S., Kyowa Kirin and its subsidiary Orchard Therapeutics have | After scoring an FDA nod Monday for the first gene therapy to treat the rare genetic disease metachromatic leukodystrophy in the U.S., Kyowa Kirin and its subsidiary Orchard Therapeutics have broken new boundaries in pricing, too.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Evolve Your Success
MARCH 20, 2024
Unlock the secrets of thriving in the competitive world of medical sales with Eddie Cortez of Integra Life Sciences’ Neurosurgery West Division. Join us as Eddy, with his 14 years of experience, shares the journey from the front lines in the operating room to leading a sales team, providing a rare glimpse into the dynamic space of neurosurgical product sales.
PharmaVoice
MARCH 22, 2024
After getting her start as a nurse, Debra Weiss worked her way up the corporate ladder and is now COO of Gates MRI, which just launched its first phase 3 trial for tuberculosis.
MedCity News
MARCH 19, 2024
AstraZeneca’s Fusion Pharmaceuticals acquisition is the latest in a wave of M&A activity that includes recent deals by Eli Lilly and Bristol Myers Squibb. The lead Fusion program is in mid-stage clinical development for treating advanced prostate cancer.
Fierce Pharma
MARCH 22, 2024
Sales are booming for Novo Nordisk’s GLP-1 treatments for diabetes and obesity. But that doesn’t mean the Danish company has moved on from its previous generation of blood sugar modulators. | With a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), Novo has come a step closer to bringing its revolutionary Awiqli (once weekly basal insulin icodec) to the market.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTimes
MARCH 21, 2024
The globally fast-growing progressive neurological condition affects around 153,000 people in the UK
PharmaVoice
MARCH 20, 2024
Orchard is counting on the long-term data it’s accrued to convince insurers to cover Lenmeldy’s $4.25 million list price, the highest of any genetic medicine to come to market.
MedCity News
MARCH 18, 2024
Will American healthcare go the way of the banking sector’s consolidation into a handful of all-powerful titans?
Fierce Pharma
MARCH 20, 2024
As two of the world’s largest pharmaceutical companies, Johnson & Johnson and Pfizer have long been rivals in various therapeutic areas. | The company is accusing former employee Andrew Brackbill of downloading thousands of confidential strategy-related files before leaving for rival Pfizer.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTimes
MARCH 20, 2024
Rare kidney diseases are a group of conditions which account for over 5% of people living with chronic kidney disease
PharmaVoice
MARCH 20, 2024
After snagging the first approval for MASH, Madrigal Pharmaceuticals’s drug is primed to become a blockbuster.
MedCity News
MARCH 18, 2024
After a healthcare cyberattack, the impacted organization often doesn’t want to divulge a lot of information, Intermountain Health CISO Erik Decker said last week at HIMSS. However, he thinks healthcare organizations should be more transparent with their peers after an attack because “no one system operates independent of everybody else.
Fierce Pharma
MARCH 20, 2024
After Johnson & Johnson last year changed its mind on its 2017 purchase of ap | Idorsia's Tryvio is the first oral anti-hypertensive therapy that uses a new therapeutic mechanism in nearly 40 years, suggesting the dawn of "a new era of endothelin research," the company said.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
MARCH 18, 2024
Akums Drugs and Pharmaceuticals has introduced Hydroxyurea oral suspension, a room temperature-stable drug for treating sickle cell disease.
PharmaVoice
MARCH 18, 2024
Pharma’s recent wins have led to pay windfalls for several company leaders.
MedCity News
MARCH 17, 2024
This year’s HIMSS conference featured a variety of news announcements — from acquisitions to new product launches to advanced partnerships. In this list, MedCity News compiled short summaries for six of the conference’s most notable announcements.
Expert insights. Personalized for you.
354 
Let's personalize your content